ONCOQUEST
The Company has assembled several bioactive technologies, including human and xenotypic monoclonal antibodies of the IgG and IgE class that can induce tumor specific immunity and enhance clinical outcome. Several of the lead components have clinical track records and extensive development dossiers that can be exploited to be integral to combinatorial immunooncology treatment strategies.
ONCOQUEST
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Wellness
Founded:
2015-01-01
Address:
Edmonton, Alberta, Canada
Country:
Canada
Website Url:
http://www.oncoquestinc.com
Total Employee:
11+
Status:
Active
Contact:
780-416-0324
Total Funding:
69.03 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Network Solutions DNS Amazon California Region Network Solutions Sun ONE Web Server Sun ONE Web Server V6.1
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.oncoquestinc.com
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OncoQuest"
OncoQuest - Crunchbase Company Profile & Funding
Sub-Organization of . Quest PharmaTech . Founded Date 2015; Founders Hany Awadalla; Operating Status Active; Last Funding Type Private Equity; Legal Name OncoQuest Inc. Company Type For Profit; Contact Email …See details»
OncoQuest Company Profile | Management and Employees List
Www.oncoquestinc.com OncoQuest Profile and History OncoQuest is a subsidiary of Quest PharmaTech Inc. (TSXV: QPT) ("Quest") and is a private biopharmaceutical company focused …See details»
OncoQuest Inc. Information Technology Solutions
OncoQuest Inc. Combinatorial Cancer Immunotherapy CORPORATE HEADQUARTERS Edmonton, AB T6E 6S4 Tel: (780) 448-1400 www.oncoquestinc.com Industry: Biotechnology/ …See details»
Oncoquest Inc Company Profile - Dun & Bradstreet
Oncoquest Inc Company Profile | Edmonton, AB, Canada | Competitors, Financials & Contacts - Dun & BradstreetSee details»
OncoQuest Company Profile - Office Locations, Competitors
OncoQuest is a company that focuses on commercializing a portfolio of immuno-modulatory antibodies for the treatment of cancer. It develops antibodies to stimulate the proliferation of …See details»
OncoQuest - Overview, News & Similar companies | ZoomInfo.com
Mar 13, 2020 The GOG Foundation, Inc (GOG) Letter of Authorization Executed Retention of IQVIA as global contract research organization for Phase 3 trial EDMONTON, Jan. 25, 2019 …See details»
OncoQuest Company Profile 2024: Valuation, Investors ... - PitchBook
OncoQuest General Information Description. Operator of a biotechnology company intended for the development of immunotherapy products for the treatment of cancer. The company …See details»
OncoQuest Lays the Groundwork for Commencement of Phase 3 …
Retention of IQVIA as global contract research organization for Phase 3 trial ... Quest PharmaTech Inc. and OncoQuest Inc., Tel: (780) 448-1400 Ext. 204, Email: …See details»
OncoQuest CEO and Key Executive Team | Craft.co
OncoQuest's Director is Bin Huang. Other executives include Madi Madiyalakan, Chief Executive Officer, Director; Eliel Bayever, Chief Medical Officer and 5 others. See the full leadership …See details»
OncoQuest aims to enhance the success of cancer immunotherapy …
OncoQuest Inc. Edmonton, Alberta, Canada Tel: +1-780-448-1400 ext. 204 Email: [email protected] contact OncoQuest Inc. oncoquestinc.com Immunologically – …See details»
OncoQuest Pharmaceuticals Inc. Announces First Patient
Sep 1, 2021 The company acquired these technologies from OncoQuest Inc. (Canada), one of the equity investee companies of Quest PharmaTech Inc., a publicly traded, Canadian based …See details»
Quest PharmaTech's Subsidiary, OncoQuest, Signs Agreement …
Mar 22, 2016 OncoQuest (www.oncoquestinc.com) is a privately held, Canadian based pharmaceutical company focused on the development and commercialization of …See details»
OncoQuest Signs a Definitive Agreement to Sell Drug ... - Newswire
Apr 22, 2020 To learn more, visit www.oncoquestinc.com . About Quest PharmaTech Inc. Quest PharmaTech Inc is a publicly traded, Canadian based biopharmaceutical company (QPT: TSX …See details»
OncoQuest Initiates Commercial Scale Oregovomab …
EDMONTON, ALBERTA, December 7, 2016 – OncoQuest Inc. (“OncoQuest’), a biopharmaceutical company focused on the development and commercialization of …See details»
OncoQuest aims to enhance the success of cancer immunotherapy …
This Canadian biotechnology company is developing combination-treatment strategies based on monoclonal antibodies to improve clinical outcomes for cancer patients.See details»
OncoQuest Lays the Groundwork for Commencement of Phase 3 …
Jan 25, 2019 Retention of IQVIA as global contract research organization for Phase 3 trial. ... Quest PharmaTech Inc. and OncoQuest Inc., Tel: (780) 448-1400 Ext. 204, Email: [email …See details»
Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First …
Nov 9, 2020 A summary of the company's work to date on Ovarian Cancer can be found at www.oncoquestinc.com About Oregovomab. Oregovomab is a murine IgG monoclonal …See details»
OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled …
Sep 1, 2021 The company acquired these technologies from OncoQuest Inc. (Canada), one of the equity investee companies of Quest PharmaTech Inc., a publicly traded, Canadian based …See details»
OncoQuest Announces Publication of Two Reports Related to …
EDMONTON, March 24, 2020 /PRNewswire/ - OncoQuest Inc. ("OncoQuest" or the "Company"), a privately held, cancer immunotherapy company today announced the publication of two …See details»
OncoQuest Lays the Groundwork for Commencement of Phase 3 …
Jan 25, 2019 The GOG Foundation, Inc (GOG) Letter of Authorization Executed. Retention of IQVIA as global contract research organization for Phase 3 trial. EDMONTON, Jan. 25, 2019 …See details»